Enigma Showcases Fully Automated rtPCR Based ML (Mini-Laboratory) for POC
Enigma Diagnostics Limited, showcased its fully automated point-of-care mini-laboratory instrument, the Enigma ML, at MEDICA 2009.
The Enigma ML offers 'Gold Standard' central reference laboratory standards of testing in an instrument developed for decentralised locations. The ML integrates a range of proprietary miniaturised technologies, including the rapid real-time PCR thermocycler and fully automated sample preparation capability, offering the only instrument platform which can deliver true raw sample to result capability in minutes in any location.
Enigma's miniaturised technology provides the paradigm shift necessary to deliver fast, accurate, low cost multi-sample instrument systems for any clinical or applied market testing at point-of-need. The ML is ideally suited for point-of-care and clinical laboratories including hospital clinics and operating rooms doctors' surgeries and pharmacies with extensive test and treat opportunities.
The affordability and ease of use of the ML instrument offers new and first time testing sites to both developed and emerging healthcare economies using previously unavailable PCR-based detection. The ML will be commercially launched in early Q3 2010 for influenza testing following clinical trials and EU/USA regulatory approvals.
Further tests will follow in 2010 and 2011.
NOTE: This item is from our 'historic' database and may contain information which is not up to date.
Source : Enigma Diagnostics Ltd. View archived contact details
Posted on November 24, 2009